Opiant Pharmaceuticals, Inc.
(NASDAQ : OPNT)

( )
OPNT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -5.13%54.750.0%$1458.59m
GILDGilead Sciences, Inc. -0.52%72.801.0%$1280.74m
AMGNAmgen, Inc. 0.05%222.501.3%$637.75m
REGNRegeneron Pharmaceuticals, Inc. -0.56%542.162.5%$613.54m
NVAXNovavax, Inc. -2.43%47.00102.0%$593.88m
VRTXVertex Pharmaceuticals, Inc. 0.12%266.821.9%$516.94m
BIIBBiogen, Inc. 0.82%298.291.6%$416.40m
ILMNIllumina, Inc. -0.08%354.413.5%$354.75m
SRNESorrento Therapeutics, Inc. 3.42%5.451.8%$317.55m
SGENSeattle Genetics, Inc. 1.50%154.006.1%$246.68m
ALXNAlexion Pharmaceuticals, Inc. 1.17%104.002.0%$226.68m
AAgilent Technologies, Inc. 1.37%86.141.6%$196.15m
CODXCo-Diagnostics, Inc. 1.72%18.340.0%$189.13m
MGNXMacroGenics, Inc. -6.82%23.646.2%$178.27m
BMRNBioMarin Pharmaceutical, Inc. 6.39%103.744.3%$172.63m

Company Profile

Opiant Pharmaceuticals, Inc. engages in the development of pharmaceutical solutions for common addictions and related disorders. It focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. Opiant Pharmaceuticals was founded on June 21, 2005 and is headquartered in Santa Monica, CA.